Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Early Intervention, Educational × Genitourinary × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Breast 3 Thoracic 2 Tumor-Agnostic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Other 1 Lymphoid 1 Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 58 Specimen Handling 54 pembrolizumab 38 enzalutamide 30 Nivolumab 28 Gemcitabine 27 Prednisone 25 Abiraterone Acetate 24 Biopsy 22 Docetaxel 20 apalutamide 19 Androgen Antagonists 19 Ipilimumab 18 darolutamide 17 Cisplatin 17 cabozantinib 16 Radiotherapy 16 enfortumab vedotin 15 X-Rays 15 Carboplatin 15 Radiosurgery 13 Pluvicto 12 Leuprolide 12 atezolizumab 10 abiraterone 10 Radiation 10 cabazitaxel 9 avelumab 9 Photons 9 Immunoglobulin G 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07302230 2026-03-13

EMPOWER

University of Washington

Phase NA Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡